Literature DB >> 36207402

CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication.

Huan Zhang1,2, Zi-Yin Zhang-Sun1,2, Cheng-Xu Xue1,2, Xi-Yang Li1,2, Jun Ren3, Yu-Ting Jiang1,2, Tong Liu1,2, Hai-Rong Yao1,2, Juan Zhang1,2, Tian-Tian Gou1,2, Ye Tian1,2, Wang-Rui Lei4,5, Yang Yang6,7.   

Abstract

C1q/tumor necrosis factor (TNF) related proteins (CTRPs) is a newly discovered adipokine family with conservative structure and ubiquitous distribution and is secreted by adipose tissues. Recently, CTRPs have attracted increasing attention due to the its wide-ranging effects upon inflammation and metabolism. To-date, 15 members of CTRPs (CTRP1-15) with the characteristic C1q domain have been characterized. Earlier in-depth phenotypic analyses of mouse models of CTRPs deficiency have also unveiled ample function of CTRPs in inflammation and metabolism. This review focuses on the rise of CTRPs, with a special emphasis on the latest discoveries with regards to the effects of the CTRP family on inflammation and metabolism as well as related diseases. We first introduced the structure of characteristic domain and polymerization of CTRPs to reveal its pleiotropic biological functions. Next, intimate association of CTRP family with inflammation and metabolism, as well as the involvement of CTRPs as nodes in complex molecular networks, were elaborated. With expanding membership of CTRP family, the information presented here provides new perspectives for therapeutic strategies to improve inflammatory and metabolic abnormalities.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  CTRPs; adipokine; atherosclerosis; heart diseases; inflammation; metabolism

Year:  2022        PMID: 36207402     DOI: 10.1038/s41401-022-00991-7

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  156 in total

1.  A novel serum protein similar to C1q, produced exclusively in adipocytes.

Authors:  P E Scherer; S Williams; M Fogliano; G Baldini; H F Lodish
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

2.  C1q/TNF-related protein 1 links macrophage lipid metabolism to inflammation and atherosclerosis.

Authors:  Xiao Qun Wang; Zhu Hui Liu; Lu Xue; Lin Lu; Jie Gao; Ying Shen; Ke Yang; Qiu Jing Chen; Rui Yan Zhang; Wei Feng Shen
Journal:  Atherosclerosis       Date:  2016-04-27       Impact factor: 5.162

3.  Loss of CTRP1 disrupts glucose and lipid homeostasis.

Authors:  Susana Rodriguez; Xia Lei; Pia S Petersen; Stefanie Y Tan; Hannah C Little; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-23       Impact factor: 4.310

4.  Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.

Authors:  G William Wong; Sarah A Krawczyk; Claire Kitidis-Mitrokostas; Tracy Revett; Ruth Gimeno; Harvey F Lodish
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

5.  A family of Acrp30/adiponectin structural and functional paralogs.

Authors:  Guang W Wong; Jin Wang; Christopher Hug; Tsu-Shuen Tsao; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

Review 6.  C1q and tumor necrosis factor superfamily: modularity and versatility.

Authors:  Uday Kishore; Christine Gaboriaud; Patrick Waters; Annette K Shrive; Trevor J Greenhough; Kenneth B M Reid; Robert B Sim; Gerard J Arlaud
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

7.  CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.

Authors:  Chang Li; Jia Wei Chen; Zhu Hui Liu; Ying Shen; Feng Hua Ding; Gang Gu; Jun Liu; Jia Pei Qiu; Jie Gao; Rui Yan Zhang; Wei Feng Shen; Xiao Qun Wang; Lin Lu
Journal:  Atherosclerosis       Date:  2018-09-28       Impact factor: 5.162

8.  Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.

Authors:  Diego Barbieri; Marian Goicoechea; Maria Dolores Sánchez-Niño; Alberto Ortiz; Eduardo Verde; Ursula Verdalles; Ana Pérez de José; Andrés Delgado; Esther Hurtado; Luis Sánchez-Cámara; Nieves Lopez-Lazareno; Ana García-Prieto; José Luño
Journal:  Clin Kidney J       Date:  2018-10-11

9.  Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation.

Authors:  Susan K Vester; Rebecca L Beavil; Steven Lynham; Andrew J Beavil; Deborah S Cunninghame Graham; James M McDonnell; Timothy J Vyse
Journal:  J Biol Chem       Date:  2021-03-04       Impact factor: 5.157

10.  C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome.

Authors:  Kyung Mook Choi; Soon Young Hwang; Ho Cheol Hong; Sae Jeong Yang; Hae Yoon Choi; Hye Jin Yoo; Kwan Woo Lee; Moon Suk Nam; Yong Soo Park; Jeong Taek Woo; Young Seol Kim; Dong Seop Choi; Byung-Soo Youn; Sei Hyun Baik
Journal:  Diabetes       Date:  2012-07-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.